Lung cancer problemPerhaps it is because of the direct feeling of the respiratory system. As the haze continues, we feel more and more people suffering from lung cancer around us. Indeed, lung cancer...
The US Food and Drug Administration (hereinafter referred to as FDA) approved Portrazza (necitumumab) in combination with gemcitabine and cisplatin in the treatment of advanced (metastatic) squamous n...
MPDL3280A, which retains the PD-L2 / PD-1 interaction, potentially reduces autoimmune lung toxicity, and has a good effect on advanced NSCLC. Platinum-based chemotherapy is still the standard first-l...
Treatment of non-small cell lung cancerThe treatment of lung cancer mainly uses surgery, radiotherapy and chemotherapy, and surgery is still the most effective method for the treatment of lung cancer ...
Non-small cell lung cancer and brain metastasis Previously, non-small cell lung cancer (NSCLC) brain metastases had a poor prognosis, with a median survival time of 7 months. But tumor-specific mutat...
Cancer genetic testing Cancer gene testing guides targeted therapy as the core technology for precise cancer treatment. Every cancer patient should perform cancer gene testing for himself, looking for...
Cancer genetic testingCancer gene testing guides targeted therapy as the core technology for precise cancer treatment. Every cancer patient should perform cancer gene testing for himself, looking for ...
Cancer related deaths in United StatesThe American Cancer Society published its 2015 annual cancer statistics report online on January 5, 2015. The cancer death rate in the United States has fallen by...
A study published online in the Journal of the American Medical Association on May 21st showed that multiple genetic tests of lung cancer tumors can help select genetic abnormalities for targeted ther...
Stereotactic body radiation therapyStereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy (SABR). Since its application in the mid-1990s, SBRT has distinguished ...